An Investigation of Classification Algorithms for Predicting HIV Drug Resistance without Genotype Resistance Testing. Lecture Notes in Computer Science (LNCS), 8315: 236-253 (2013).

Publication Latest Publications

Title: An Investigation of Classification Algorithms for Predicting HIV Drug Resistance without Genotype Resistance Testing
Authors: Brandt P, Moodley D, Pillay AW, Seebregts CJ, de Oliveira T.
Journal: Lecture Notes in Computer Science (LNCS),8315:236-253 (2013)

Journal Impact Factor (I.F.): 1.2
Number of citations (Google Scholar): 1

Abstract

The development of drug resistance is a major factor impeding the efficacy of antiretroviral treatment of South Africa?s HIV infected population. While genotype resistance testing is the standard method to determine resistance, access to these tests is limited in low-resource settings.

In this paper we investigate machine learning techniques for drug resistance prediction from routine treatment and laboratory data to help clinicians select patients for confirmatory genotype testing. The techniques, including binary relevance, HOMER, MLkNN, predictive clustering trees (PCT), RAkEL and ensemble of classifier chains were tested on a dataset of 252 medical records of patients enrolled in an HIV treatment failure clinic in rural KwaZulu-Natal in South Africa.

The PCT method performed best with a discriminant power of 1.56 for two drugs, above 1.0 for three others and a mean true positive rate of 0.68. These methods show potential for application where access to genotyping is limited.

Download: Full text paper

Citation: Brandt P, Moodley D, Pillay AW, Seebregts CJ, de Oliveira T. An Investigation of Classification Algorithms for Predicting HIV Drug Resistance without Genotype Resistance Testing Lecture Notes in Computer Science (LNCS),8315:236-253 (2013).


High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor?Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)

CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients
Journal: Current HIV Research (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013